Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

HSKA Relative to the S&P 500

HSKA Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Heska Corp. (NASD:HSKA) seasonal charts above shows that a Buy Date of December 16 and a Sell Date of March 13 has resulted in a geometric average return of 16.68% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 15 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 10.86% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Heska Corp is engaged in developing, manufacturing, marketing, selling & supporting veterinary products. The company’s products include Point of Care diagnostic laboratory instruments and consumables; Point of Care digital imaging diagnostic products; reference laboratory testing; digital cytology services; vaccines; local and cloud-based data services; allergy testing and immunotherapy; single-use offerings such as in-clinic diagnostic tests and heartworm preventive products; and practice information management software and related software. It operates through two segments North America and International. The Company’s core strategic focus on Point of Care laboratory and imaging products is included in both segments.

To download HSKA seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: HSKA